£112.04

Academic Press Overcoming Ovarian Cancer Chemoresistance (Volume 11) (Cancer Sensitizing Agents for Chemotherapy, Volume 11)

Price data last checked 21 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£112 today · previous high £112 · all-time low £108

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 70 days · 70 data points (no recent data)

Historical
Generating forecast…
£112.04 £108.04 £108.91 £109.78 £110.66 £111.53 £112.40 02 May 2026 19 May 2026 05 June 2026 22 June 2026 10 July 2026

Price Distribution

Price distribution over 70 days • 4 price levels

Days at Price
Current Price
16 days 8 days 11 days 35 days · current 0 9 18 26 35 £108 £109 £110 £112 Days at Price

Price Analysis

Most common price: £112 (35 days, 50.0%)

Price range: £108 - £112

Price levels: 4 different prices over 70 days

Description

Overcoming Ovarian Cancer Chemoresistance presents non-overlapping review chapters that discuss the state of the field in overcoming chemoresistance of ovarian cancer and treatment options before and following recurrence, considering the genetic makeup of the ovarian cancer patient and her tumor. With the uptake of both germline and somatic gene testing, clinicians can obtain a more comprehensive understanding of ovarian tumors and this book provides information to link the genetic makeup of a tumor (or patient) with the best available treatment. The book discusses topics such as strategies to fight chemo-resistance in ovarian cancer, circulating DNA as a monitor of response, BRCA mutations, ovarian cancer stem cells, immunotherapy and vaccines. Additionally, it brings a list of promising agents at clinical and pre-clinical stage that will impact the treatment in the near future. This book is a valuable source for cancer researchers, oncologists and several members of biomedical field who need to understand how to battle chemoresistance in ovarian cancer. Provides a comprehensive view of both biological and genetic determinants of resistance, as well as technical approaches to monitor response Discusses genetic reversions as a unique alteration and a new field of study Includes a chapter on upcoming and promising agents that are in the pre-clinical and early clinical space, to set the stage for future directions in the field

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
14 November 2020
Listed Since
01 October 2019

Barcode

No barcode data available

Similar Products You Might Like

Advances in Diagnosis and Management of Ovarian Cancer
96% match

Advances in Diagnosis and Management of Ovarian Cancer

Springer

£119.99 06 Jul 2026
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes
96% match

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes

Springer

£107.85 13 Jul 2026
The Tumor Microenvironment of High Grade Serous Ovarian Cancer
96% match

The Tumor Microenvironment of High Grade Serous Ovarian Cancer

MDPI AG

£64.85 16 Jul 2026
Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)
96% match

Optimizing Breast Cancer Management: 173 (Cancer Treatment and Research, 173)

Springer

£52.63 03 Jul 2026
Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)
96% match

Translational Research in Breast Cancer: Biomarker Diagnosis, Targeted Therapies and Approaches to Precision Medicine: 1026 (Advances in Experimental Medicine and Biology, 1026)

Springer

£140.72 09 Jul 2026
Etiology of Breast and Gynecological Cancers (Progress in Clinical and Biological Research)
96% match

Etiology of Breast and Gynecological Cancers (Progress in Clinical and Biological Research)

Wiley-Blackwell

£181.49 09 Jul 2026
Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)
96% match

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)

Springer

£135.35 08 Jul 2026
Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)
96% match

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Humana

£141.73 10 Jul 2026
Gynecologic Radiation Oncology: A Practical Guide
96% match

Gynecologic Radiation Oncology: A Practical Guide

Lippincott Williams & Wilkins

£86.87 19 Jun 2026
Springer Uterine Cancer: Screening, Diagnosis, and Treatment
96% match

Springer Uterine Cancer: Screening, Diagnosis, and Treatment

Springer

£104.44 15 Jul 2026
DiSaia and Creasman Clinical Gynecologic Oncology
96% match

DiSaia and Creasman Clinical Gynecologic Oncology

Elsevier

£120.42 23 Jun 2026
Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)
96% match

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Academic Press

£113.99 08 Jul 2026
Gender and Cancer in England, 1860-1948 (Medicine and Biomedical Sciences in Modern History)
96% match

Gender and Cancer in England, 1860-1948 (Medicine and Biomedical Sciences in Modern History)

MACMILLAN

£73.85 09 Jul 2026
Clinical Cancer Prevention: 188 (Recent Results in Cancer Research, 188)
96% match

Clinical Cancer Prevention: 188 (Recent Results in Cancer Research, 188)

Springer

£80.66 15 Jul 2026
Translational Advances in Gynecologic Cancers
96% match

Translational Advances in Gynecologic Cancers

Academic Press

£77.19 10 Jul 2026
Breast Cancer: Methods and Protocols: 1406 (Methods in Molecular Biology, 1406)
95% match

Breast Cancer: Methods and Protocols: 1406 (Methods in Molecular Biology, 1406)

Humana

£79.50 06 Jul 2026
Precision Medicine in Gynecology and Obstetrics (Comprehensive Gynecology and Obstetrics)
95% match

Precision Medicine in Gynecology and Obstetrics (Comprehensive Gynecology and Obstetrics)

Springer

£107.19 09 Jul 2026
Hereditary Gynecologic Cancer: Risk, Prevention and Management
95% match

Hereditary Gynecologic Cancer: Risk, Prevention and Management

CRC Press

£185.00 17 Jun 2026
Atlas of Clear Cell Carcinoma of the Ovary: A Pathological Guide
95% match

Atlas of Clear Cell Carcinoma of the Ovary: A Pathological Guide

Springer

£74.31 06 Jul 2026
Ovarian Cancer: 23 (Cancer Treatment and Research)
95% match

Ovarian Cancer: 23 (Cancer Treatment and Research)

Springer

£129.53 18 Jun 2026
Pathology of Female Cancers: Precursor and Early-Stage Breast, Ovarian and Uterine Carcinomas
95% match

Pathology of Female Cancers: Precursor and Early-Stage Breast, Ovarian and Uterine Carcinomas

Springer

£106.57 13 Jul 2026
Epigenetics of Cancer Prevention (Volume 8) (Translational Epigenetics, Volume 8)
95% match

Epigenetics of Cancer Prevention (Volume 8) (Translational Epigenetics, Volume 8)

Academic Press

£96.51 13 Jul 2026
Metastasis: Methods and Protocols: 2294 (Methods in Molecular Biology, 2294)
95% match

Metastasis: Methods and Protocols: 2294 (Methods in Molecular Biology, 2294)

Humana

£104.12 15 Jul 2026
Diagnostic Pathology: Breast 4th Ed - Essential Clinical Reference
95% match

Diagnostic Pathology: Breast 4th Ed - Essential Clinical Reference

Elsevier

£160.91 25 Jun 2026